CompletedNot Applicable

Mannitol Administration for Delerium Prevention

Russia50 participantsStarted 2024-12-29

Plain-language summary

The aim of the study is to evaluate the efficacy of adjuvant administration of mannitol for the prevention of delirium in patients with myocardial infarction.

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 65 and over * Myocardial infarction in the first day of illness ("pain to door" time \< 254 hours) * Serum CRP \> 25 mg/L Exclusion Criteria: * A known pathological process in the brain, psychiatric disorders * Impossibility of conducting an assessment CAM-ICU

What they're measuring

delirium

Timeframe: 1-14 days

Trial details

NCT IDNCT06759259

SponsorTomsk National Research Medical Center of the Russian Academy of Sciences

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-02-01

View on ClinicalTrials.gov More Myocardial Infarction (MI) trials